Interleukin enhancer-binding factor 3 (ILF3) Peptide
Quick Overview for Interleukin enhancer-binding factor 3 (ILF3) Peptide (ABIN936729)
Target
Origin
Source
Application
-
-
Peptide Type
- Synthetic
-
Sequence
- ALKAVSDWID EQEKGSSEQA ESDNMDVPPE DDSKEGAGEQ KTEHMTRTLR
-
Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of ILF3 antibody,
Alternative Names: ILF3 control peptide, ILF3 antibody Blocking Peptide, Anti-ILF3 Blocking Peptide, Interleukin Enhancer Binding Factor 3 90Kda Blocking Peptide, ILF3, ILF-3, ILF 3, ILF-3 Blocking Peptide, ILF 3 Blocking Peptide
-
-
-
-
Application Notes
- Optimal conditions should be determined by the investigator
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Handling Advice
- Avoid repeated freeze/thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20 °C long term.
-
-
- Interleukin enhancer-binding factor 3 (ILF3)
-
Background
- ILF3 may facilitate double-stranded RNA-regulated gene expression at the level of post-transcription. ILF3 can act as a translation inhibitory protein which binds to coding sequences of acid beta-glucosidase (GCase) and other mRNAs and functions at the initiation phase of GCase mRNA translation, probably by inhibiting its binding to polysomes. ILF3 can regulate protein arginine N-methyltransferase 1 activity.
-
Molecular Weight
- 76 kDa
Target
-